Improved performances of the second generation of the ID NOW influenza A&B 2® and comparison with the GeneXpert®

[1]  Y. Kawaoka,et al.  Sensitivity of Commercially Available Influenza Rapid Diagnostic Tests in the 2018–2019 Influenza Season , 2019, Front. Microbiol..

[2]  F. Janvier,et al.  Influenza B false-positive results by rapid molecular tests Alere™ i Influenza A&B 2 in France. , 2019, Diagnostic microbiology and infectious disease.

[3]  P. Brotons,et al.  Impact of Rapid On-demand Molecular Diagnosis of Pediatric Seasonal Influenza on Laboratory Workflow and Testing Costs: A Retrospective Study. , 2019, The Pediatric infectious disease journal.

[4]  T. File,et al.  Clinical Practice Guidelines by the Infectious Diseases Society of America: 2018 Update on Diagnosis, Treatment, Chemoprophylaxis, and Institutional Outbreak Management of Seasonal Influenzaa. , 2019, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[5]  Ye-ming Wang,et al.  Comparison of the Cepheid Xpert Xpress Flu/RSV assay and commercial real-time PCR for the detection of influenza A and influenza B in a prospective cohort from China. , 2019, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.

[6]  B. Tiran,et al.  Prospective evaluation of three rapid molecular tests for seasonal influenza in patients presenting at an emergency unit. , 2019, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

[7]  T. File,et al.  Clinical Practice Guidelines by the Infectious Diseases Society of America: 2018 Update on Diagnosis, Treatment, Chemoprophylaxis, and Institutional Outbreak Management of Seasonal Influenzaa. , 2019, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[8]  A. Wong,et al.  Comparison of the Cepheid Xpert Xpress Flu/RSV Assay to in-house Flu/RSV triplex real-time RT-PCR for rapid molecular detection of Influenza A, Influenza B and Respiratory Syncytial Virus in respiratory specimens. , 2018, Journal of medical microbiology.

[9]  E. Popowitch,et al.  Comparison of the Xpert Flu/RSV XC and Xpress Flu/RSV Assays , 2018, Journal of Clinical Microbiology.

[10]  J. H. Chen,et al.  Evaluation of the molecular Xpert Xpress Flu/RSV assay vs. Alere i Influenza A & B assay for rapid detection of influenza viruses. , 2017, Diagnostic microbiology and infectious disease.

[11]  B. Lina,et al.  Implementation of Alere i Influenza A & B point of care test for the diagnosis of influenza in an ED , 2017, The American journal of emergency medicine.

[12]  S. Young,et al.  Diagnostic accuracy of the real-time PCR cobas® Liat® Influenza A/B assay and the Alere i Influenza A&B NEAR isothermal nucleic acid amplification assay for the detection of influenza using adult nasopharyngeal specimens. , 2017, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

[13]  D. Price,et al.  Diagnostic accuracy and cost analysis of the Alere™ i Influenza A&B near-patient test using throat swabs. , 2017, The Journal of hospital infection.

[14]  Benjamin J Cowling,et al.  Viral Shedding and Transmission Potential of Asymptomatic and Paucisymptomatic Influenza Virus Infections in the Community , 2016, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[15]  F. Nolte,et al.  Direct Comparison of Alere i and cobas Liat Influenza A and B Tests for Rapid Detection of Influenza Virus Infection , 2016, Journal of Clinical Microbiology.

[16]  Mi-Ae Jang,et al.  Comparison of two new generation influenza rapid diagnostic tests with instrument-based digital readout systems for influenza virus detection , 2016, British journal of biomedical science.

[17]  M. Fuentes-Ferrer,et al.  Evaluation of the Alere i Influenza A&B assay for rapid identification of influenza A and influenza B viruses. , 2016, Journal of medical microbiology.

[18]  S. Behillil,et al.  Prospective evaluation of the Alere i Influenza A&B nucleic acid amplification versus Xpert Flu/RSV. , 2016, Diagnostic microbiology and infectious disease.

[19]  M. Waris,et al.  Performance of the Alere i influenza A&B assay and mariPOC test for the rapid detection of influenza A and B viruses. , 2015, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

[20]  D. Dwyer,et al.  Detection of influenza A and B with the Alere™ i Influenza A & B: a novel isothermal nucleic acid amplification assay , 2015, Influenza and other respiratory viruses.

[21]  T. Pumarola,et al.  Evaluation of a new, rapid, simple test for the detection of influenza virus , 2015, BMC Infectious Diseases.

[22]  K. Chapin,et al.  Performance of the Molecular Alere i Influenza A&B Test Compared to That of the Xpert Flu A/B Assay , 2014, Journal of Clinical Microbiology.

[23]  R. Selvarangan,et al.  Evaluation of the Alere i Influenza A&B Nucleic Acid Amplification Test by Use of Respiratory Specimens Collected in Viral Transport Medium , 2014, Journal of Clinical Microbiology.

[24]  N. E. Babady,et al.  Evaluation of Alere i Influenza A&B for Rapid Detection of Influenza Viruses A and B , 2014, Journal of Clinical Microbiology.

[25]  Bernstein,et al.  Clinical Practice Guidelines by the Infectious Diseases Society of America: 2018 Update on Diagnosis, Treatment, Chemoprophylaxis, and Institutional Outbreak Management of Seasonal Influenza a , 2018 .